Want to join the conversation?
Eric Wasserstrom of Guggenheim Securities probes about treasury and trade solutions outlook. $C CFO John Gerspach said that all of the trade performance is in the number reported and is pretty much how the company is operating today. $C has moved a lot more of its trade business into being less balance sheet intensive.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?